GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME Study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 02 2021
Historique:
received: 04 09 2020
accepted: 30 11 2020
entrez: 27 2 2021
pubmed: 28 2 2021
medline: 15 12 2021
Statut: epublish

Résumé

To analyze functional and anatomical response patterns to dexamethasone (DEX) implant in diabetic macular edema (DME), to describe proportion of responders and non-responders, and to propose a new DME grading system. Retrospective, multicenter, observational cohort study. Naïve and non-naïve DME patients were treated with DEX, with visual acuity (VA) ≥ 0.2 logMAR and central subfield thickness (CST) of ≥ 300 µm. Functional and anatomical responses were graded after 2 and 4 months, and categorized as early and stable improvement, early and progressive improvement, pendular response, delayed improvement, and persistent non-response. 417 eyes were included (175 treatment naïve eyes). Compared to non-naïve eyes, naïve eyes showed a very good functional response (VA gain ≥ 10 letters) more frequently after 2 and 4 months (56% and 57% [naïve] vs. 33% and 28% [non-naïve], p < 0.001). A VA gain < 5 letters (non-response) after 2 and 4 months was seen in 18% and 16% of naïve eyes, and in 49% and 53% of non-naïve eyes (p < 0.001). A lack of anatomical response was rare in both groups, but more frequently in non-naïve eyes (12% vs. 4%, p = 0.003). Functionally and anatomically, naïve eyes showed most frequently an early and stable improvement (functionally: 77/175 44%; anatomically: 123/175 eyes, 70%). Most non-naïve eyes experienced no significant improvement functionally (97/242 eyes, 40%), despite a mostly early and stable improvement anatomical response pattern (102/242 eyes, 42%). Functional but not anatomical response patterns were influenced by baseline VA. Naïve and non-naïve eyes show different functional and anatomical response patterns to DEX implant. Functional non-responders are rare in naïve eyes, whereas anatomical non-response is unusual in both groups.

Identifiants

pubmed: 33637772
doi: 10.1038/s41598-020-79288-w
pii: 10.1038/s41598-020-79288-w
pmc: PMC7910444
doi:

Substances chimiques

Angiogenesis Inhibitors 0
Dexamethasone 7S5I7G3JQL

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

4738

Références

Retina. 2019 Jan;39(1):44-51
pubmed: 29697589
Am J Ophthalmol. 2018 Nov;195:209-222
pubmed: 30098350
Retina. 2019 Jan;39(1):88-97
pubmed: 29474302
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
Ophthalmology. 2014 Oct;121(10):1904-14
pubmed: 24907062
Am J Ophthalmol. 2018 Nov;195:93-100
pubmed: 30077569
Ophthalmology. 2015 Jul;122(7):1395-401
pubmed: 25870079
Ophthalmol Retina. 2018 Mar;2(3):231-234
pubmed: 31047591
Ophthalmology. 2018 Feb;125(2):267-275
pubmed: 28935399
Ophthalmol Retina. 2018 Jun;2(6):567-573
pubmed: 31047610
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
Ophthalmologica. 2015;233(3-4):176-85
pubmed: 25661239
Ophthalmology. 2016 Jun;123(6):1345-50
pubmed: 26992841
Ophthalmologica. 2017;237(4):185-222
pubmed: 28423385
Ophthalmology. 2014 Dec;121(12):2473-81
pubmed: 25155371
Retina. 2018 Jun;38(6):1110-1119
pubmed: 28613220
Retina. 2017 Apr;37(4):753-760
pubmed: 27471826
Br J Ophthalmol. 2018 Apr;102(4):479-482
pubmed: 28779007
Am J Ophthalmol. 2016 Dec;172:72-79
pubmed: 27644589
Ophthalmology. 2020 Mar;127(3):377-393
pubmed: 31932090

Auteurs

Patricio J Rodríguez-Valdés (PJ)

Instituto de Oftalmología y Ciencias Visuales, Escuela de Medicina, Tecnológico de Monterrey, Monterrey, Mexico.

Matus Rehak (M)

Department of Ophthalmology, University Hospital Leipzig, Liebigstr. 10-14, 04103, Leipzig, Germany.

Dinah Zur (D)

Division of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Anna Sala-Puigdollers (A)

Institut Clínic d'Oftalmología (ICOF), Hospital Clinic de Barcelona, Barcelona, Spain.

Samantha Fraser-Bell (S)

Department of Ophthalmology, Sydney University, Sydney, Australia.

Marco Lupidi (M)

Department of Surgical and Biomedical Sciences, Section of Ophthalmology, University of Perugia, Perugia, Italy.

Jay Chhablani (J)

UPMC Eye Center, University of Pittsburgh, Pittsburgh, USA.
L.V. Prasad Eye Institute, Banjara Hills, Hyderabad, India.

Zafer Cebeci (Z)

Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Inês Laíns (I)

Massachusetts Eye and Ear, Harvard Medical School, Boston, USA.
Association for Innovation and Biomedical Research on Light, Coimbra, Portugal.

Voraporn Chaikitmongkol (V)

Retina Division, Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Adrian T Fung (AT)

Westmead and Central Clinical Schools, Discipline of Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, Australia.
Department of Ophthalmology, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.

Mali Okada (M)

Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.

Jan Darius Unterlauft (JD)

Department of Ophthalmology, University Hospital Leipzig, Liebigstr. 10-14, 04103, Leipzig, Germany.

Lital Smadar (L)

Division of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Anat Loewenstein (A)

Division of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Incumbent, Sydney A. Fox Chair in Ophthalmology, Tel Aviv University, Tel Aviv, Israel.

Matias Iglicki (M)

Private Retina Service, University of Buenos Aires, Buenos Aires, Argentina.

Catharina Busch (C)

Department of Ophthalmology, University Hospital Leipzig, Liebigstr. 10-14, 04103, Leipzig, Germany. busch.catharina@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH